Abstract
MicroRNAs (miRNAs) play critical roles in cancer development and progression. In this study, we examined the roles and molecular mechanisms of miR-342-3p in human non-small cell lung cancer (NSCLC). The results showed that miR-342-3p is downregulated in NSCLC cell lines and tissues, and its overexpression induces significant inhibition of NSCLC cell proliferation, invasion, and tumor growth in nude mice. In addition, miR-342-3p repressed RAP2B expression through interactions with its 3′-UTR region. Restoration of RAP2B expression reversed miR-342-3p-mediated inhibitory activity in NSCLC cells. Finally, analyses of miR-342-3p and RAP2B levels in NSCLCs revealed that miR-342-3p inversely correlated with RAP2B mRNA expression. Our collective findings provide preliminary evidence that miR-342-3p acts as a tumor suppressor in NSCLC through repression of RAP2B.
Similar content being viewed by others
References
Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin. 2010;60:277–300.
Yokota J, Kohno T. Molecular footprints of human lung cancer progression. Cancer Sci. 2004;95:197–204.
Pallis AG, Fennell DA, Szutowicz E, Leighl NB, Greillier L, Dziadziuszko R. Biomarkers of clinical benefit for anti-epidermal growth factor receptor agents in patients with non-small-cell lung cancer. Br J Cancer. 2011;105:1–8.
Cai J, Wu J, Zhang H, Fang L, Huang Y, Yang Y, et al. Mir-186 downregulation correlates with poor survival in lung adenocarcinoma, where it interferes with cell-cycle regulation. Cancer Res. 2013;73:756–66.
Bartel DP. Micrornas: target recognition and regulatory functions. Cell. 2009;136:215–33.
Ambros V. The functions of animal micrornas. Nature. 2004;431:350–5.
Kloosterman WP, Plasterk RH. The diverse functions of micrornas in animal development and disease. Dev Cell. 2006;11:441–50.
Wang R, Wang ZX, Yang JS, Pan X, De W, Chen LB. Microrna-451 functions as a tumor suppressor in human non-small cell lung cancer by targeting ras-related protein 14 (rab14). Oncogene. 2011;30:2644–58.
Esquela-Kerscher A, Slack FJ. Oncomirs—micrornas with a role in cancer. Nat Rev Cancer. 2006;6:259–69.
Kent OA, Mendell JT. A small piece in the cancer puzzle: micrornas as tumor suppressors and oncogenes. Oncogene. 2006;25:6188–96.
Acunzo M, Visone R, Romano G, Veronese A, Lovat F, Palmieri D, et al. Mir-130a targets met and induces trail-sensitivity in nsclc by downregulating mir-221 and 222. Oncogene. 2012;31:634–42.
Gu H, Yang T, Fu S, Chen X, Guo L, Ni Y. Microrna-490-3p inhibits proliferation of a549 lung cancer cells by targeting ccnd1. Biochem Biophys Res Commun. 2014;444:104–8.
Ke Y, Zhao W, Xiong J, Cao R. Downregulation of mir-16 promotes growth and motility by targeting hdgf in non-small cell lung cancer cells. FEBS Lett. 2013;587:3153–7.
Cai J, Fang L, Huang Y, Li R, Yuan J, Yang Y, et al. Mir-205 targets pten and phlpp2 to augment akt signaling and drive malignant phenotypes in non-small cell lung cancer. Cancer Res. 2013;73:5402–15.
Wang J, Tian X, Han R, Zhang X, Wang X, Shen H, et al. Downregulation of mir-486-5p contributes to tumor progression and metastasis by targeting protumorigenic arhgap5 in lung cancer. Oncogene. 2014;33:1181–9.
Dacic S, Kelly L, Shuai Y, Nikiforova MN. Mirna expression profiling of lung adenocarcinomas: correlation with mutational status. Mod Pathol. 2010;23:1577–82.
Wang H, Wu J, Meng X, Ying X, Zuo Y, Liu R, et al. Microrna-342 inhibits colorectal cancer cell proliferation and invasion by directly targeting DNA methyltransferase 1. Carcinogenesis. 2011;32:1033–42.
Li XR, Chu HJ, Lv T, Wang L, Kong SF, Dai SZ. Mir-342-3p suppresses proliferation, migration and invasion by targeting foxm1 in human cervical cancer. FEBS Lett. 2014;588:3298–307.
Tiscornia G, Singer O, Verma IM. Production and purification of lentiviral vectors. Nat Protoc. 2006;1:241–5.
Yi C, Wang Q, Wang L, Huang Y, Li L, Liu L, et al. Mir-663, a microrna targeting p21(waf1/cip1), promotes the proliferation and tumorigenesis of nasopharyngeal carcinoma. Oncogene. 2012;31:4421–33.
Zheng B, Liang L, Wang C, Huang S, Cao X, Zha R, et al. Microrna-148a suppresses tumor cell invasion and metastasis by downregulating rock1 in gastric cancer. Clin Cancer Res. 2011;17:7574–83.
Fernandez S, Risolino M, Mandia N, Talotta F, Soini Y, Incoronato M, et al. Mir-340 inhibits tumor cell proliferation and induces apoptosis by targeting multiple negative regulators of p27 in non-small cell lung cancer. Oncogene. 2014.
Gu Y, Cheng Y, Song Y, Zhang Z, Deng M, Wang C, et al. Microrna-493 suppresses tumor growth, invasion and metastasis of lung cancer by regulating e2f1. PLoS One. 2014;9:e102602.
Fourie NH, Peace RM, Abey SK, Sherwin LB, Rahim-Williams B, Smyser PA, et al. Elevated circulating mir-150 and mir-342-3p in patients with irritable bowel syndrome. Exp Mol Pathol. 2014;96:422–5.
Montag J, Hitt R, Opitz L, Schulz-Schaeffer WJ, Hunsmann G, Motzkus D. Upregulation of mirna hsa-mir-342-3p in experimental and idiopathic prion disease. Mol Neurodegener. 2009;4:36.
Grady WM, Parkin RK, Mitchell PS, Lee JH, Kim YH, Tsuchiya KD, et al. Epigenetic silencing of the intronic microrna hsa-mir-342 and its host gene evl in colorectal cancer. Oncogene. 2008;27:3880–8.
Fayyad-Kazan H, Bitar N, Najar M, Lewalle P, Fayyad-Kazan M, Badran R, et al. Circulating mir-150 and mir-342 in plasma are novel potential biomarkers for acute myeloid leukemia. J Transl Med. 2013;11:31.
He YJ, Wu JZ, Ji MH, Ma T, Qiao EQ, Ma R, et al. Mir-342 is associated with estrogen receptor-alpha expression and response to tamoxifen in breast cancer. Exp Ther Med. 2013;5:813–8.
Tao K, Yang J, Guo Z, Hu Y, Sheng H, Gao H, et al. Prognostic value of mir-221-3p, mir-342-3p and mir-491-5p expression in colon cancer. Am J Transl Res. 2014;6:391–401.
Farrell FX, Ohmstede CA, Reep BR, Lapetina EG. Cdna sequence of a new ras-related gene (rap2b) isolated from human platelets with sequence homology to rap2. Nucleic Acids Res. 1990;18:4281.
Ohmstede CA, Farrell FX, Reep BR, Clemetson KJ, Lapetina EG. Rap2b: a ras-related gtp-binding protein from platelets. Proc Natl Acad Sci U S A. 1990;87:6527–31.
Zhang X, He Y, Lee KH, Dubois W, Li Z, Wu X, et al. Rap2b, a novel p53 target, regulates p53-mediated pro-survival function. Cell Cycle. 2013;12:1279–91.
Di JH, Qu DB, Lu Z, Li LT, Cheng Q, Xin Y, Zhang LZ, Zhang Y, Zheng JN. Rap2b promotes migration and invasion of human suprarenal epithelioma. Tumour Biol 2014
Liu Y, Sun W, Zhang K, Zheng H, Ma Y, Lin D, et al. Identification of genes differentially expressed in human primary lung squamous cell carcinoma. Lung Cancer. 2007;56:307–17.
Fu G, Liu Y, Yuan J, Zheng H, Shi T, Lei W, et al. identification and functional analysis of a novel candidate oncogene rap2b in lung cancer. Zhongguo Fei Ai Za Zhi. 2009;12:273–6.
Acknowledgment
This study was supported by two grant from the National Natural Science Foundation of China (No. 81071924 and 81372520).
Author information
Authors and Affiliations
Corresponding author
Additional information
Xiao Xie and Hongtao Liu contributed equally to this work.
Rights and permissions
About this article
Cite this article
Xie, X., Liu, H., Wang, M. et al. miR-342-3p targets RAP2B to suppress proliferation and invasion of non-small cell lung cancer cells. Tumor Biol. 36, 5031–5038 (2015). https://doi.org/10.1007/s13277-015-3154-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13277-015-3154-3